Initial studies showed that both quercetin and kaempferol bound NR4A1 and in vitro studies confirmed that both compounds exhibited inverse NR4A1 agonist activities in rhabdomyosarcoma cells and inhibited tumor growth in an athymic mouse xenograft model (Zhang et al., 2023). This evidence concerns the gene NR4A1 and rhabdomyosarcoma.